A novel quinoline derivative that inhibits mycobacterial FtsZ

Tuberculosis

Volumn 93, Issue 4, 2013, Pages 398-400

  Mathew, Bini ^a   Ross, Larry ^a   Reynolds, Robert C ^a  

^a SOUTHERN RESEARCH INSTITUTE   (United States)

Author keywords

Tuberculosis FtsZ Quinoline

Indexed keywords

6 CHLORO 2 METHYL N(4 PROPOXYPHENYL)QUINOLIN 4 AMINE; FTSZ PROTEIN; N METHYL 4 PROPOXYANILINE; QUINOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; CELL DIVISION; CYTOTOXICITY; GROWTH INHIBITION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHARMACOPHORE; PRIORITY JOURNAL;

ANIMALS; ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; CERCOPITHECUS AETHIOPS; CYTOSKELETAL PROTEINS; DRUG DESIGN; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR TARGETED THERAPY; MYCOBACTERIUM TUBERCULOSIS; QUINOLINES; VERO CELLS;

EID: 84878937952     PISSN: 14729792     EISSN: 1873281X     Source Type: Journal    
DOI: 10.1016/j.tube.2013.04.002     Document Type: Article

References (29)

1. A. Koul, E. Arnoult, N. Lounis, J. Guillemont, and K. Andries The challenge of new drug discovery for tuberculosis Nature 469 2011 483 490
2. R.C. Goldman, and B.E. Laughon Discovery and validation of new antitubercular compounds as potential drug leads and probes Tuberculosis (Edinb) 89 2009 331 333
3. J.A. Maddry, S. Ananthan, R.C. Goldman, J.V. Hobrath, C.D. Kwong, C. Maddox, L. Rasmussen, R.C. Reynolds, J.A. Secrist III, M.I. Sosa, E.L. White, and W. Zhang Antituberculosis activity of the molecular libraries screening center network library Tuberculosis (Edinb) 89 2009 354 363
4. S. Ananthan, E.R. Faaleolea, R.C. Goldman, J.V. Hobrath, C.D. Kwong, B.E. Laughon, J.A. Maddry, A. Mehta, L. Rasmussen, R.C. Reynolds, J.A. Secrist III, N. Shindo, D.N. Showe, M.I. Sosa, W.J. Suling, and E.L. White High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv Tuberculosis (Edinb) 89 2009 334 353
5. R.C. Reynolds, S. Ananthan, E. Faaleolea, J.V. Hobrath, C.D. Kwong, C. Maddox, L. Rasmussen, M.I. Sosa, E. Thammasuvimol, E.L. White, W. Zhang, and J.A. Secrist III High throughput screening of a library based on kinase inhibitor scaffolds against Mycobacterium tuberculosis H37Rv Tuberculosis (Edinb) 92 2012 72 83
6. D.J. Payne, M.N. Gwynn, D.J. Holmes, and D.L. Pompliano Drugs for bad bugs: confronting the challenges of antibacterial discovery Nat Rev Drug Discov 6 2007 29 40
7. E.W. Barrow, W.J. Suling, L.E. Seitz, R.C. Reynolds, and W.W. Barrow New antifolate inhibitors for Mycobacterium Avium Med Chem 2 2006 505 510
8. V. Usha, J.V. Hobrath, S.S. Gurcha, R.C. Reynolds, and G.S. Besra Identification of novel Mt-Guab2 inhibitor series active against M. tuberculosis PLOS One 7 2012 e33886
9. E.L. White, W.J. Suling, L.J. Ross, L.E. Seitz, and R.C. Reynolds 2-Alkoxycarbonylpyridines: inhibitors of Mycobacterium tuberculosis FtsZ J Antimicrob Chemother 50 2002 111 114
10. A. Lilienkampf, J. Mao, B. Wan, Y. Wang, S.G. Franzblau, and A.P. Kozikowski Structure-activity relationships for a series of quinoline-based compounds active against replicating and nonreplicating Mycobacterium Tuberculosis J Med Chem 52 2009 2109 2118
11. J. Mao, Y. Wang, B. Wan, A.P. Kozikowski, and S.G. Franzblau Design, synthesis, and pharmacological evaluation of mefloquine-based ligands as novel antituberculosis agents ChemMedChem 2 2007 1624 1630
12. S. Jayaprakash, Y. Iso, B. Wan, S.G. Franzblau, and A.P. Kozikowski Design, synthesis, and SAR studies of mefloquine-based ligands as potential antituberculosis agents ChemMedChem 1 2006 593 597
13. K. Andries, P. Verhasselt, J. Guillemont, H.W.H. Goehlmann, J.-M. Neefs, H. Winkler, J. Van Gestel, P. Timmerman, M. Zhu, E. Lee, P. Williams, D. de Chaffoy, E. Huitric, S. Hoffner, E. Cambau, C. Truffot-Pernot, N. Lounis, and V.A. Jarlier Diarylquinoline drug active on the ATP synthase of Mycobacterium Tuberculosis Sci 307 2005 223 227
14. N. Sirisoma, A. Pervin, H. Zhang, S. Jiang, J. Adam Willardsen, M.B. Anderson, G. Mather, C.M. Pleiman, S. Kasibhatla, B. Tseng, J. Drewe, and S.X. Cai Discovery of N-methyl-4-(4-methoxyanilino)quinazolines as potent apoptosis inducers. Structure-activity relationship of the quinazoline ring Bioorg Med Chem Lett 20 2010 2330 2334
15. N. Sirisoma, A. Pervin, H. Zhang, and S. Jiang Adam Willardsen J, Anderson MB, Mather G, Pleiman CM, Kasibhatla S, Tseng B, Drewe J, Cai SX. Discovery of N-(4-methoxyphenyl)-N,2-dimethylquinazolin-4-amine, a potent apoptosis inducer and efficacious anticancer agent with high blood brain barrier penetration J Med Chem 52 2009 2341 2351
16. N. Sirisoma, S. Kasibhatla, A. Pervi, H. Zhang, S. Jiang, J.A. Willardsen, M.B. Anderson, V. Baichwal, G.G. Mather, K. Jessing, R. Hussain, K. Hoang, C.M. Pleiman, B. Tseng, J. Drewe, and S.X. Cai Discovery of 2-chloro-N-(4-methoxyphenyl)-N-methylquinazolin-4-amine (EP128265, MPI-0441138) as a potent inducer of apoptosis with high in vivo activity J Med Chem 51 2008 4771 4779
17. S. Ma, and S. Ma The development of FtsZ inhibitors as potential antibacterial agents Chem Med Chem 7 2012 1161 1172
18. N.R. Stokes, N. Baker, J.M. Bennett, J. Berry, I. Collins, L.G. Czaplewski, A. Logan, R. Macdonald, L. Macleod, H. Peasley, J.P. Mitchell, N. Nayal, A. Yadav, A. Srivastava, and D.J. Haydon An improved small-molecule inhibitor of FtsZ with superior in vitro potency, drug-like properties, and in vivo efficacy Antimicrob Agents Chemother 57 2013 317 325
19. K. Kumar, D. Awasthi, S.-Y. Lee, I. Zanardi, B. Ruzsicska, S. Knudson, P.J. Tonge, R.A. Slayden, and I. Ojima Novel trisubstituted benzimidazoles, targeting Mtb FtsZ, as a new class of antitubercular agents J Med Chem 54 2011 374 381
20. D.J. Haydon, N.R. Stokes, R. Ure, G. Galbraith, J.M. Bennett, D.R. Brown, P.J. Baker, V.V. Barynin, D.W. Rice, S.E. Sedelnikova, J.R. Heal, J.M. Sheridan, S.T. Aiwale, P.K. Chauhan, A. Srivastava, A. Taneja, I. Collins, J. Errington, and L.G. Czaplewski An inhibitor of FtsZ with potent and selective anti-staphylococcal activity Science 321 2008 1673 1675
21. K. Kumar, D. Awasthi, W.T. Berger, P.J. Tonge, R.A. Slayden, and I. Ojima Discovery of anti-TB agents that target the cell-division protein FtsZ Future Med Chem 2 2010 1305 1323
22. G. Urgaonkar, S.L.H. Pierre, I. Meir, H. Lund, D.R. Chaudhuri, and J.T. Shaw Synthesis of antimicrobial natural products targeting FtsZ: (±)-dichamanetin and (±)-2'''-hydroxy-5''-benzylisouvarinol-B Org Lett 7 2005 5609 5612
23. J. Wang, A. Galgoci, S. Kodali, K.B. Hearth, H. Jayasuriya, K. Dorso, F. Vicente, A. Gonzalez, D. Cully, D. Bramhill, and S. Singh Discovery of a small molecule that inhibits cell division by blocking FtsZ, a novel therapeutic target of antibiotics J Biol Chem 278 2003 44424 44428
24. D.N. Margailt, L. Romberg, R.B. Mets, A.M. Hebert, T.J. Mitchinson, M.W. Krischner, and D.R. Chaudhuri Targeting cell division: small-molecule inhibitors of FtsZ GTPase perturb cytokinetic ring assembly and induce bacterial lethality Proc Natl Acad Sci USA 101 2004 11821 11826
25. H.P. Erickson FtsZ, a prokaryotic homolog of tubulin Cell 80 1995 367 370
26. B. Mathew, S. Srivastava, L.J. Ross, W.J. Suling, E.L. White, L.K. Woolhiser, A.J. Lenaerts, and R.C. Reynolds Novel pyridopyrazine and pyrimidothiazine derivatives as FtsZ inhibitors Bioorg Med Chem 19 2011 7120 7128
27. R.C. Reynolds, S. Srivastava, L.J. Ross, W.J. Suling, and E.L. White A new 2-carbamoyl pteridine that inhibits mycobacterial FtsZ Bioorg Med Chem Lett 14 2004 3161 3164
28. C. Temple, J.D. Rose, R.D. Elliot, and J.A. Montgomery Synthesis of potential antimalarial agents. II. 6,8-Disubstituted pyrido[2,3-b]pyrazines J Med Chem 11 1968 1216 1218
29. S.B. Kadin Monomethylation of aromatic amines via sodium borohydride mediated carbon-nitrogen bond cleavage J Org Chem 38 1973 1348 1350